Carlos Buesa

Chief Executive Officer (CEO)

A founder of the Company in 2000, he has held the position of Chair of the Board of Directors since then. He earned his Ph.D. in Biochemistry from the University of Barcelona, and has completed various programs on finance and negotiation. He also completed the Senior Management Program (PADE) at IESE in 2005. In recent years, he has been a member of the board of several biotechnology companies, such as: ONCNOSIS PHARMA AIE, NINFAS AIE, ORYCAMB-PROJECT AIE, GEADIG-PHARMA AIE, NEUROTEC PHARMA, S.L., PALOBIOFARMA, S.L. He has been a member of the Advisory Board of NEUROSCIENCES TECHNOLOGIES and is a member of MENDELION, S.L. He is also a member of the Board of Directors of INVEREADY SEED CAPITAL and of INVEREADY BIOTECH since September 7, 2008 and October 10, 2012, respectively.

First appointment as Director: 20 february 2002
Re-election: 02 september 2020

Company shares: CNMV